FDA Approved: PAZOPANIB — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved an original Abbreviated New Drug Application for Pazopanib by Apotex Corp., providing a generic version of the cancer drug Pazopanib. The approval …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

ORIG AP for PAZOPANIB (PAZOPANIB)